Digi Intl Analyst Ratings
Armada Hoffler Properties Analyst Ratings
CommVault Systems Analyst Ratings
Cactus Analyst Ratings
Stifel Nicolaus Sticks to Their Buy Rating for Iovance Biotherapeutics (IOVA)
Wedbush Lifts Price Target on LendingClub to $11 From $10, Maintains Outperform Rating
B. Riley Raises Price Target on Magnite to $18.50 From $14.50, Keeps Buy Rating
Patterson-UTI Energy Analyst Ratings
Oil States International Analyst Ratings
Liberty Energy Analyst Ratings
Morgan Stanley Raises Price Target on Treace Medical Concepts to $8 From $5.50, Keeps Equalweight Rating
Jefferies Downgrades Morphic Holding to Hold From Buy, Price Target Is $57
Helmerich & Payne Analyst Ratings
Morgan Stanley Boosts Price Target on TransMedics Group to $145 From $104, Keeps Equalweight Rating
Core Laboratories Analyst Ratings
Morgan Stanley Lowers Price Target on SI-Bone to $21 From $25, Keeps Overweight Rating
Truist Financial Reaffirms Their Buy Rating on Corcept Therapeutics (CORT)
Truist Financial Keeps Their Buy Rating on Instructure Holdings (INST)
ChampionX Analyst Ratings
Jefferies Downgrades Armada Hoffler Properties to Hold From Buy, Adjusts Price Target to $11 From $13